Richard worked at Eli Lilly and Company in several leadership positions including Vice President for Neuroscience Early Clinical Development and Leader of the Global Alzheimer’s Drug Development team. He spent 23 years with the Mount Sinai School of Medicine as a Professor in the Department of Psychiatry and Associate Chief of Staff for Research at the Bronx Veterans Affairs Medical Center. Richard is the author or co-author of over 350 scientific papers, is a consultant to several academic institutions, is a member of the Board of Governors for the Alzheimer’s Drug Discovery Foundation (ADDF) and is a member of the Board of Directors of the Greater Indiana Chapter of the Alzheimer’s Association. He received a PhD in psychology from Stanford University and completed postdoctoral training in Pharmacology at the Stanford Medical School.